| Health Technology Assessment 1999; Vol. 3: No. 5
Executive summary
View/Download full
monograph in Adobe Acrobat format (578 kbytes)
View/Download this
4-page summary in Adobe Acrobat format (suitable for printing)
Methods for evaluating area-wide and organisation-based interventions in health and
health care: a systematic review
OC Ukoumunne
MC Gulliford
S Chinn
JAC Sterne
PGJ Burney
Department of Public Health Sciences, Guy's, King's and St Thomas' School of
Medicine, King's College London, UK
Background
Health technology assessment often requires the evaluation of interventions which are
implemented at the level of geographical area or health service organisational unit.
Examples include health promotion interventions implemented in schools, workplaces or
neighbourhoods, screening programmes in health authority populations, and healthcare
interventions in general practices or hospitals. Interventions like these are implemented
for clusters of individuals. Evaluation of cluster-based interventions presents a number
of difficulties but some evidence suggests these are not always addressed in an optimal
manner.
Aims and objectives
This report describes a systematic review of methods for evaluating cluster-based
interventions. There were three objectives:
- to review the methodological literature and synthesise the findings into a checklist for
practical use
- to evaluate existing practice in healthcare evaluation
- to present intraclass correlations for a range of outcome variables at different levels
of organisational clustering in order to provide information for the design of future
cluster-based studies.
Methods
- The review focused on methods for evaluating health and healthcare interventions that
are implemented for clusters of patients or healthy individuals. References were obtained
by handsearching journals, searching electronic databases, screening cited references,
contacting expert informants, and searching the world wide web. Synthesis into a
methodological checklist was by means of qualitative judgements concerning validity.
- A review of seven health science journals in 1996 yielded 56 papers reporting
evaluations of cluster-based interventions. Evaluation against the checklist of
methodological recommendations identified the main departures from good practice.
- A database of intraclass correlations was compiled by analysing data from a variety of
sources.
Methodological recommendations
The main methodological findings of the review were synthesised into a 12-point
checklist for investigators.
- Recognise the cluster as the unit of intervention or allocation. It is important
to distinguish between cluster level and individual level intervention, as failure to do
so can result in studies which are inappropriately designed or which give incorrect
results.
- Justify the use of the cluster as the unit of intervention or allocation. For a
fixed number of individuals, studies in which clusters are allocated are not as powerful
as traditional clinical trials in which individuals are randomised. The decision to
allocate at cluster level should be justified on theoretical, practical or economic
grounds.
- Include a sufficient number of clusters. Evaluation of an intervention
implemented in a single cluster will not usually give generalisable results. Valid designs
should include a control group not receiving the intervention. Both intervention and
control groups should include enough clusters to allow the effect of intervention to be
distinguished from natural variability among clusters. Studies with fewer than four
clusters per group are unlikely to yield statistically significant results, and more
clusters will be required if relevant intervention effects are small.
- Randomise clusters wherever possible. The need for randomisation is generally
accepted in the evaluation of individual level interventions but randomisation of clusters
has not been practised as often as it should be in the evaluation of cluster-based
interventions. Because of the risk of bias, use of quasi-experimental or observational
designs should always be justified.
- In non-randomised studies include a control group. When randomisation is not
feasible, a control group should be included. Each group should include a sufficient
number of clusters (see point 3). The clusters allocated to groups should be stratified
for important prognostic factors so far as possible (see point 8) and a wide range of
confounders should be measured. Outcome variables should be measured before and after the
intervention.
- In single group studies include repeated measurements over time. Sometimes it is
not feasible to include a control group, as, for example, when a new policy is implemented
at national level. In this case, repeated assessments should be made both before and after
the intervention in order to control for secular changes in the outcome.
- Allow for clustering when estimating the required sample size. The total number
of individuals required can be estimated by multiplying the result of a standard sample
size calculation by the design effect. This will require an estimate of the intraclass
correlation coefficient, which should be obtained from previous studies.
- Consider the use of pairing or stratification of clusters where appropriate.
Cluster-based evaluations often include small numbers of clusters, and simple
randomisation is unlikely to yield groups that are balanced with respect to cluster level
baseline characteristics. Stratification or pairing of clusters according to
characteristics that are associated with the outcome may reduce error in randomised
studies and reduce bias in non-randomised studies. Limitations of the paired, or matched,
design are underappreciated.
- Consider different approaches to repeated assessments in prospective evaluations.
Either cohort or repeated cross-sectional designs may be used to sample individuals in
studies with follow-up. The cohort design is more applicable to individual level outcomes,
and may yield more precise results but is more susceptible to bias. The repeated
cross-sectional design is more appropriate when outcomes will be aggregated to cluster
level; it is usually less powerful but is less susceptible to bias.
- Allow for clustering at the time of analysis. Standard statistical methods
applied to individual level outcomes should not be used because they will give confidence
intervals that are too narrow and p values that are too small. There are three valid
approaches to analysis: cluster level analysis, in which the cluster means or proportions
are used as units of analysis; adjusted individual level analysis, in which standard
univariate statistical methods are adjusted for the design effect; regression methods for
clustered data, which allow for both individual and cluster level variation (hierarchical
analysis). When the number of clusters is small, cluster level analysis will be most
appropriate because between-cluster variation cannot be estimated with sufficient
precision to implement analyses at the individual level. Regression methods for clustered
data will usually be required for non-randomised designs.
- Allow for confounding at both individual and cluster level. Standard multiple
regression methods are not appropriate. Use of regression methods for clustered data will
allow the incorporation of both individual and cluster level confounders in the analysis.
This approach will increase precision in randomised studies and reduce bias in
non-randomised designs.
- Include estimates of intraclass correlation and components of variance in published
reports. In order to provide information that may be used to estimate sample size
requirements for future studies, estimates of the intraclass correlation coefficient
should be included in published reports.
Case study: a review of seven health science journals
A review of 56 papers reporting evaluations of cluster-based interventions from seven
health science journals showed that the present level of adherence to the methodological
recommendations of the review was low. The main departures from recommendations were the
evaluation of interventions in small numbers of clusters, and the incorrect use of
standard methods for individual level analysis.
A database of intraclass correlation coefficients
In order to provide information which may be used in the design of future studies, the
report presents intraclass correlation coefficients and components of variance for a range
of outcomes in five areas: cardiovascular and lifestyle, cancer, respiratory, health
service activity, and other. For community-based studies, data are presented for
individuals clustered at the level of household, postcode sector and district and regional
health authority. For healthcare-based studies, data are presented for clustering at the
level of general practice, hospital, district health authority and family health services
authority.
Publication
Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for
evaluating area-wide and organisation-based interventions in health and health care: a
systematic review.Health Technol Assessment 1999; 3(5).
NHS R&D HTA Programme
The overall aim of the NHS R&D Health Technology Assessment (HTA)
programme is to ensure that high quality research information on the costs, effectiveness
and broader impact of health technologies is produced in the most efficient way for those
who use, manage and work in the NHS. Research is undertaken in those areas where the
evidence will lead to the greatest benefits to patients, either through improved patient
outcomes or the most efficient use of NHS resources.
The Standing Group on Health Technology advises on national priorities
for health technology assessment. Six advisory panels assist the Standing Group in
identifying and prioritising projects. These priorities are then considered by the HTA
Commissioning Board supported by the National Coordinating Centre for HTA.
This report is one of a series covering acute care, diagnostics and
imaging, methodology, pharmaceuticals, population screening, and primary and community
care. It was identified as a priority by the Methodology Panel and funded as project
number 94/09/01.
The views expressed in this publication are those of the authors and
not necessarily those of the Standing Group, the Commissioning Board, the Panel members or
the Department of Health. The editors wish to emphasize that funding and publication of
this research by the NHS should not be taken as implicit support for the recommendations
for policy contained herein. In particular, policy options in the area of screening will
be considered by the National Screening Committee. This Committee, chaired by the Chief
Medical Officer, will take into account the views expressed here, further available
evidence and other relevant considerations.
Reviews in Health Technology Assessment are termed 'systematic'
when the account of the search, appraisal and synthesis methods (to minimise biases and
random errors) would, in theory, permit the replication of the review by others.
Series Editors:
Andrew Stevens, Ruairidh Milne, Ken Stein
Assistant Editor:
Melanie Corris
The editors have tried to ensure the accuracy of this report but cannot
accept responsibility for any errors or omissions. They would like to thank the referees
for their constructive comments on the draft document.
©1999 Crown Copyright |